Treatment stage What may be common What deserves attention Week 1 Nausea, fullness, reduced appetite, bloating, indigestion, diarrhea, constipation, fatigue Repeated vomiting, severe pain, inability to stay hydrated Weeks 2 to 4 Early symptoms may settle, persist, or fluctuate Symptoms interfering with eating, drinking, or daily function Weeks 5 to 8 Symptoms may reappear after clinician-directed dose escalation A significant return or worsening of gastrointestinal symptoms Months 2 to 3 Some patients tolerate treatment more comfortably

Available now starting at $79.99/month Weight Loss Protocol Semaglutide Get Started Free priority shipping Compounded in US-based pharmacies Board-certified doctors Weight Loss Protocol Semaglutide Starting at $79.99 The better way to lose weight No membership fees, transparent pricing Unlimited messaging with your doctor No in-person visit or insurance required Starting at $150 per month How it works Semaglutide, a FDA approved GLP-1 receptor agonist, mimics the hormones that regulate blood sugar levels and appetite
As reflected in the evolving strategies of food manufacturers and the food service industry, there is a growing recognition of the need to adapt product offerings to support individuals experiencing medication-induced appetite suppression
If you are taking oral contraceptive pills and starting tirzepatide or increasing your dose, the FDA recommends implementing additional contraceptive protection
It also states that compounded semaglutide should never be initiated, adjusted, or discontinued without medical supervision